Treatment with inhaled corticosteroids in asthma is too often discontinued
Authors:
- Ron M. C. HeringsRHRon M. C. Herings
- for the CAMERA Study GroupFGfor the CAMERA Study Group
- 26 March 2008
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 17 (4) , 411-422
Abstract
Purpose: To study persistence with inhaled corticosteroids (ICS) and its determinants in asthma‐patients.Methods: From the PHARMO database, asthma‐patients (age < 35 years) with a first dispensing for ICS in 1999–2002 and ≥ 2 dispensings in the first year were included. Persistence during the first year was defined as the number of days from start to time of first failure to continue renewal of the initial ICS. Potential determinants of persistence were assessed at ICS‐start and 1 year before.Results: The study‐cohort included 5563 new users of single ICS and 297 of fixed‐combined ICS. Less than 10% of patients using single ICS and 15% of patients using fixed‐combined ICS were persistent at 1 year. Similar persistence‐rates were observed when stratified for age (children/adolescents: 0–18 years and adults: 19–34 years). Increased persistence with single ICS was observed with the type of ICS (budesonide), prescriber (specialist), prior use of long‐acting beta‐agonists, previous hospitalization for asthma, metered‐dose inhaler, low starting‐dose and once‐daily dosing regimen at start. Persistence with fixed combined ICS‐treatment increased with younger age and was decreased in patients having high starting‐dose of ICS and prior use of antibiotics.Conclusion: New users of both single and fixed combined ICS have alarming low persistence rates with ICS‐treatment in the first year of follow‐up. Persistence was mainly related to patient factors, such as severity of disease, and to treatment‐related factors, such as once‐daily dosing frequency. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 41 references indexed in Scilit:
- Treatment Persistence with Leukotriene Receptor Antagonists and Inhaled CorticosteroidsJournal of Asthma, 2005
- Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costsPrimary Care Respiratory Journal, 2005
- Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapiesJournal of Allergy and Clinical Immunology, 2004
- Inhaled CorticosteroidsJournal of Allergy and Clinical Immunology, 2003
- Budesonide/formoterol for the treatment of asthmaExpert Opinion on Pharmacotherapy, 2003
- Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthmaThorax, 2002
- Predictors of Long-term Persistence on Statins in a Subsidized Clinical PopulationValue in Health, 2000
- Decrease in asthma mortality rate in Israel from 1991-1995: Is it related to increased use of inhaled corticosteroids?Journal of Allergy and Clinical Immunology, 2000
- The costs of asthmaEuropean Respiratory Journal, 1996
- Dry Powder Inhalers: Advantages and LimitationsJournal of Aerosol Medicine, 1991